BIOMAT Database Logo BIOMAT Database Logo

Cerebral atrophy, macrosomia, and cutaneous telangiectasia in GM1 gangliosidosis. 1985

M G Goetting, and M J Dasouki

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D005733 Gangliosidoses A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway. Ganglioside Storage Diseases,Ganglioside Storage Disorders,Gangliosidosis,Ganglioside Storage Disease,Ganglioside Storage Disorder,Storage Disease, Ganglioside,Storage Diseases, Ganglioside,Storage Disorder, Ganglioside,Storage Disorders, Ganglioside
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001284 Atrophy Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. Atrophies
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D013684 Telangiectasis Permanent dilation of preexisting blood vessels (CAPILLARIES; ARTERIOLES; VENULES) creating small focal red lesions, most commonly in the skin or mucous membranes. It is characterized by the prominence of skin blood vessels, such as vascular spiders. Spider Veins,Telangiectasia,Spider Vein,Telangiectases,Telangiectasias,Vein, Spider,Veins, Spider

Related Publications

M G Goetting, and M J Dasouki
[GM1 gangliosidosis].
January 1981, Ceskoslovenska pediatrie,
M G Goetting, and M J Dasouki
GM1 gangliosidosis.
January 1974, Journal of the neurological sciences,
M G Goetting, and M J Dasouki
[GM1 gangliosidosis].
January 2001, Ryoikibetsu shokogun shirizu,
M G Goetting, and M J Dasouki
Cerebral GM1-gangliosidosis: chemical pathology of visceral organs.
March 1968, Science (New York, N.Y.),
M G Goetting, and M J Dasouki
Hyperphosphatasemia in GM1 gangliosidosis.
January 1992, The Journal of pediatrics,
M G Goetting, and M J Dasouki
GM1-gangliosidosis (gneralized gangliosidosis). Morphology and chemical pathology.
January 1968, Pathologia Europaea,
M G Goetting, and M J Dasouki
Gm1-gangliosidosis and juvenile cerebral lipidosis. Clinical, histochemical, and chemical study.
June 1971, Archives of neurology,
M G Goetting, and M J Dasouki
GM1 Gangliosidosis: Mechanisms and Management.
January 2021, The application of clinical genetics,
M G Goetting, and M J Dasouki
[GM1 gangliosidosis and dilated cardiomyopathy].
January 1990, Klinische Padiatrie,
M G Goetting, and M J Dasouki
GM1 gangliosidosis, type II.
February 1982, Indian pediatrics,
Copied contents to your clipboard!